Costs, Effectiveness of Laparoscopic, Open Gastrectomy Similar
THURSDAY, Dec. 29, 2022 (HealthDay News) -- After one-year follow-up, differences in the total costs and effectiveness of laparoscopic and open gastrectomy are minimal, according to a study published online Dec. 28 in JAMA Surgery.
Arjen van der Veen, M.D., Ph.D., from the University Medical Center Utrecht in the Netherlands, and colleagues examined the cost-effectiveness of laparoscopic versus open gastrectomy in a multicenter randomized clinical trial of patients undergoing total or distal gastrectomy for resectable gastric adenocarcinoma. Data were included for 227 patients between 2015 and 2018.
The researchers found that the unit costs for initial surgery were calculated as €8,124, €7,353, €6,584, and €5,893 for laparoscopic total gastrectomy, laparoscopic distal gastrectomy, open total gastrectomy, and open distal gastrectomy, respectively. After one-year follow-up, the mean total costs were €26,084 and €25,332 in the laparoscopic and open groups, respectively (difference, €752). During one year, the mean quality-adjusted life year contributions were 0.665 and 0.686 in the laparoscopic and open groups, respectively. Compared with the uncertainty of the analysis, bootstrapping showed that the differences between the groups were relatively small.
"The comparable cost-effectiveness between treatment groups in the current study supports centers' choosing, based on their own preference, whether to (de)implement laparoscopic gastrectomy as an alternative to open gastrectomy," the authors write.
Several authors disclosed financial ties to the medical device industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
First Shots Given in Trial of Moderna’s mRNA-Based HIV Vaccine
TUESDAY, Feb. 1, 2022 (HealthDay News) -- Vaccinations have been given to the...
Newer Mesh Slings for Stress Incontinence a Safe, Effective Option for Women: Study
THURSDAY, March 31, 2022 (HealthDay News) -- For women with frequent urine...
Five-Year Relative Survival 59.6 Percent in Lower-Risk Myelodysplastic Syndromes
WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- About 40 percent of patients with...
Opioid Tapering Tied to Overdose, Withdrawal, Mental Health Risks for Up to Two Years
WEDNESDAY, June 29, 2022 (HealthDay News) -- Opioid tapering is associated with...